Musement raises €690k from 360 Capital Partners and IAG (Italian Angels for Growth) to expand internationally

Venture Capital firm 360 Capital Partners and the business angels network Italian Angels for Growth injected €690,000 in the italian, an interesting hub for the world of cultural tourism and art events.  The Milan-based startup has raised a total of 690 thousand Euros by IAG members, 360 Capital Partners and a third investor, amount that will be allocated to the development of Musement's app and platform, expanding the range of services provided, for the geographical expansion and strengthening of the structure and for marketing and communications activities. The startup showcases last 30th April, 2013 at TechCrunch Disrupt in New York, introducing its unique service of its kind with the target to emprove users experience in cultural tourism and art events.

Musement.com - which allows access to more than 60 museums, archeological sites and theaters in 25 cities in Italy and which will launch by the end of 2013 its offer abroad (France, UK and USA) and mobility services thanks also to the agreement with Charta (www.vivaticket.it) and Teleart, the ticketing firms of the Best Union group -  is an Italian project, the brainchild of four entrepreneurs - Claudio Bellinzona, Paolo Giulini, Alessandro Petazzi , Fabio Zecchini - with the aim to bring together in one place all of the cultural market, which still can not "create a system". Its function is also to simplify the organization and thus improving the visit of many tourists traveling to cultivate their passions.

Read More

Angiodroid received €900k ($1.16M) in Seed funding from Italian Angels for Growth (IAG) and Zeta MetaVentures

Bologna, 23rd October 2013 - One more time a group of members of Italian Angels for Growth (IAG), the principal Italian network of angel investors, aimed at the field of medical devices and innovation result of Italian research. Italian Angels for Growth has indeed invested €900k ($1.16M) along with Zernita Meta Ventures (for the fund Ingenieum Emilia Romagna II) in the bologna-based start-up Angiodroid Srl, operating in the sector of medical technologies. This €900k could double if determined objectives will be reached commented Angiodroid CEO Sebastiano Zannoli to the financial newspaper "Il Sole 24 Ore".

It is a first round - startup investment aimed at developing new products and a business network in Europe, India, Canada, the Middle East, China, Brazil, Africa. As Michele Marzola, the business angel who coordinated the preparatory operations to close the investment from the side of IAG's shareholders: "Italy expresses excellence both in innovation and in the realization of new medical devices allowing to improve the clinical efficacy on patients and reduce health costs at the same time. Angiodroid is one of those Italian champions in a market in constant growth. The elements that persuaded us to invest in Angiodroid - continues Marzola - are combination the of an innovative product that is already appreciated in the halls angiographic with a team strong, which is characterized by scientific excellence and growth orientation of society."

THE TECHNOLOGY 
Angiodroid, founded by two brothers Sebastiano (current CEO) and Samuel Zannoli (software development manager), has developed a medical technology capable of automatically exploiting CO2 characteristics (carbon dioxide) as contrast medium for many different kinds of medical operations (operational radiology, vascular surgery and hemodynamics) in which are currently being used other chemical elements (in angiography usually iodine or iodine-based compounds). Angiodroid's innovative medical technology represent the first fully automated system to perform angiography that uses carbon dioxide as a contrast medium alternative to iodine, thus ensuring greater safety, particularly in patients with renal diseases, thus allowing a completely painless and safe exploration of the blood vessels, with excellent image definition. The funding will be used to develop new products and the sales network in Europe, India, Canada, Middle East, China, Brazil and Africa.

Read More

Italian the Best European Business Angel 2011

The European Business Angels Association (EBAN) which on May 13, 2011 met in Warsaw for its Annual Meeting, awarded Francesco Marini Clarelli - president of Italian Angels for Growth (IAG) - as best European Business Angel of the Year, 2011. 

EBAN is the trade association that brings together at European level, supports and represents business angels, groups of angel investors, seed funds and other actors operating in the world of early-stage investments. Overall, with its presence in 26 countries where it operates, through direct and indirect membership, EBAN involves more than 300 groups, 20,000 business angels and 40,000 entrepreneurs. For the next few years the organization has set itself the ambitious goal of bringing the early-stage investment level from the current estimated value of € 4 billion to € 10 billion.

Is therefore understandable the satisfaction with which Marini Clarelli (53 years, angel investor since for more than 20 years) has welcomed the award:

Read More